Keywords: آپیکسابان; Venous thromboembolism; Cancer; New oral anticoagulants; Apixaban; Dabigatran; Rivaroxaban; Edoxaban
مقالات ISI آپیکسابان (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آپیکسابان; anticoagulation; apixaban; dabigatran etexilate; deep vein thrombosis; rivaroxaban; venous thromboembolism
Keywords: آپیکسابان; Venous thromboembolism; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Warfarin;
Keywords: آپیکسابان; Bleeding; Safety; Dabigatran; Rivaroxaban; Apixaban; Prothrombin complex concentrates;
Keywords: آپیکسابان; Atrial fibrillation; Stroke; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Keywords: آپیکسابان; Dabigatran; Apixaban; Rivaroxaban; Traveller's thrombosis; Anticoagulation
Keywords: آپیکسابان; apixaban; bleeding; dabigatran; direct oral anticoagulant; edoxaban; management; pharmacology; rivaroxaban; ACS; acute coronary syndrome; AF; atrial fibrillation; ASA; acetylsalicylic acid; bid; twice daily; CrCl; creatinine clearance; CYP; cytochrome P45
Keywords: آپیکسابان; AF; Atrial fibrillation; OAC; Oral anticoagulant; INR; International normalised ratio; TTR; Time in therapeutic range; NOAC; Novel oral anticoagulant; ARISTOTLE; Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation; AVER
Keywords: آپیکسابان; Stroke prevention; apixaban; cost-effectiveness; atrial fibrillation; new oral anticoagulant;
Keywords: آپیکسابان; Dabigatran; Rivaroxaban; Apixaban;
Keywords: آپیکسابان; Apixaban; Direct factor Xa inhibitors; Tandem mass spectrometry; Liquid chromatography; Anticoagulants;
Comparative Effectiveness and Safety of Apixaban and Vitamin K Antagonist Therapy in Patients With Nonvalvular Atrial Fibrillation Treated in Routine German Practice
Keywords: آپیکسابان; Anticoagulant; Vitamin k antagonist; Apixaban; Non-valvular atrial fibrillation; Stroke;
Use of DOAC Stop for elimination of anticoagulants in the thrombin generation assay
Keywords: آپیکسابان; Thrombin generation assay; Direct oral anticoagulants; DOAC adsorbent; Dabigatran; Rivaroxaban; Edoxaban; Apixaban;
Point of Care Testing (POCT) to assess drug concentration in patients treated with non-vitamin K antagonist oral anticoagulants (NOACs)
Keywords: آپیکسابان; Apixaban; Concentration; Dabigatran; Emergency; Point of Care Test; Rivaroxaban;
Sub therapeutic rivaroxaban plasma concentrations following administration via Percutaneous Endoscopic Gastrostomy (PEG) feeding tubes - A note of caution
Keywords: آپیکسابان; Absorption; Apixaban; Feeding tubes; Rivaroxaban; Stroke;
Simple method for removing DOACs from plasma samples
Keywords: آپیکسابان; DOAC; Dabigatran; Apixaban; Rivaroxaban; Edoxaban; APTT; dRVVT; Lupus anticoagulant; Clotting tests; DOAC adsorbent;
The safety and efficacy of non-vitamin K antagonist oral anticoagulants in atrial fibrillation in the elderly
Keywords: آپیکسابان; Apixaban; Atrial fibrillation; Dabigatran; Non-vitamin K antagonist oral anticoagulant; Edoxaban; Rivaroxaban;
Apixaban attenuates ischemia-induced myocardial fibrosis by inhibition of Gq/PKC signaling
Keywords: آپیکسابان; Apixaban; Myocardial ischemia; Myocardial fibrosis; Thrombin; Collagen deposition; Gq/PKC signaling;
Factor Xa inhibition and sPESI failure in intermediate-high-risk pulmonary embolism
Keywords: آپیکسابان; Apixaban; Pulmonary embolism; Intermediate high-risk pulmonary embolism; Thrombolysis; NOACs; sPESI;
Analysis of Recurrent Stroke Volume and Prognosis between Warfarin and Four Non-Vitamin K Antagonist Oral Anticoagulants' Administration for Secondary Prevention of Stroke
Keywords: آپیکسابان; Stroke volume; recurrent; NOAC; DOAC; direct thrombin inhibitor; dabigatran; factor Xa inhibitor; rivaroxaban; apixaban; edoxaban; warfarin;
What have we learned from real-world NOAC studies in venous thromboembolism treatment?
Keywords: آپیکسابان; Real world evidence; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Venous thromboembolism;
Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal
Keywords: آپیکسابان; acetylsalicylic acid; clopidogrel; prasugrel; ticagrelor; dabigatran; rivaroxaban; apixaban; warfarin; heparin; low molecular weight heparin; proton pump inhibitors; Bleeding; Chronic kidney disease; Management; Risk;
Measurement of apixaban, dabigatran, edoxaban and rivaroxaban in human plasma using automated online solid-phase extraction combined with ultra-performance liquid chromatography-tandem mass spectrometry and its comparison with coagulation assays
Keywords: آپیکسابان; aPTT; activated partial thromboplastin time; BEH; bridged ethyl hybrid; CV; coefficient of variation; DOACs; direct oral anticoagulants; DTI; direct thrombin inhibitor(s); IS; internal standard; MRM; multiple reaction monitoring mode; MS/MS; tandem mass s
Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
Keywords: آپیکسابان; Anticoagulation; Apixaban; Atrial fibrillation; Bleeding; History of falls; Stroke; Warfarin;
QCM-D sensor for the dose management of Apixaban in replacement surgery
Keywords: آپیکسابان; QCM-D; Apixaban; Surgery; Patients; aPTT; TT;
Pharmacokinetic drug interactions of the non-vitamin K antagonist oral anticoagulants (NOACs)
Keywords: آپیکسابان; Apixaban (CID: 10182969); Betrixaban (CID: 10275777) dabigatran etexilate (CID: 216210); Edoxaban (CID: 10280735); Rivaroxaban (CID: 9875401); Warfarin (CID:â54678486); Apixaban; Betrixaban; Dabigatran etexilate; Edoxaban; Rivaroxaban; Warfarin;
Spontaneous Superior Mesenteric Artery Branch Pseudoaneurysm: A Rare Case Report
Keywords: آپیکسابان; Visceral arterial pseudoaneurysm; Superior mesenteric artery; Apixaban; Coils;
Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention
Keywords: آپیکسابان; Atrial fibrillation; Drug-eluting stent; Triple therapy; Apixaban;
Non-vitamin K antagonist oral anticoagulants and the management of bleeding
Keywords: آپیکسابان; Apixaban; bleeding; dabigatran; edoxaban; NOAC; rivaroxaban;
Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit
Keywords: آپیکسابان; Antifibrinolytics; Apixaban; Bleeding; Dabigatran; Factor concentrates; Factor VIIa; Fibrinogen; Hemorrhage; Prothrombin complex concentrates; Rivaroxaban;
Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life
Keywords: آپیکسابان; Anticoagulants; Major bleeding; Intracranial hemorrhage; Dabigatran; Rivaroxaban; Apixaban;
Permanent discontinuation of non vitamin K oral anticoagulants in real life patients with non-valvular atrial fibrillation
Keywords: آپیکسابان; Dabigatran; Rivaroxaban; Apixaban; Atrial fibrillation; Discontinuation; Anticoagulants;
Anticoagulation therapy and clinical outcomes in patients with recently diagnosed atrial fibrillation: Insights from the ARISTOTLE trial
Keywords: آپیکسابان; Apixaban; Anticoagulation; Atrial fibrillation; Recently diagnosed atrial fibrillation; Stroke prevention;
Factor Eight Inhibitor Bypassing Agent (FEIBA) for Reversal of Target-Specific Oral Anticoagulants in Life-Threatening Intracranial Bleeding
Keywords: آپیکسابان; FEIBA; target-specific oral anticoagulants; life-threatening bleeding; dabigatran; rivaroxaban; apixaban; intracranial hemorrhage; anti-xa inhibitor; anticoagulation; reversal;
International Normalized Ratio Is Significantly Elevated With Rivaroxaban and Apixaban Drug Therapies: A Retrospective Study
Keywords: آپیکسابان; anticoagulants; apixaban; direct anti-factor Xa inhibitors; DOACs; INR elevation; rivaroxaban;
Choosing wisely: The impact of patient selection on efficacy and safety outcomes in the EINSTEIN-DVT/PE and AMPLIFY trials
Keywords: آپیکسابان; anticoagulation; rivaroxaban; apixaban; venous thromboembolism;
Anticoagulation in Pulmonary Embolism: Update in the Age of Direct Oral Anticoagulants
Keywords: آپیکسابان; Direct Oral Anticoagulants; Dabigatran; Rivaroxaban; Apixaban; Edoxaban; Anticoagulation; Pulmonary Embolism; Deep Vein Thrombosis;
Apixaban for the treatment of cerebral venous thrombosis: A case series
Keywords: آپیکسابان; Cerebral venous thrombosis; Anticoagulation; Direct oral anticoagulants; Apixaban;
Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial
Keywords: آپیکسابان; Apixaban; Atrial fibrillation; Cancer; Stroke; Systemic embolism; Warfarin;
Combined factor IIa and Xa inhibitor therapy for thrombosis whilst on therapeutic anticoagulant
Keywords: آپیکسابان; Recurrent venous thrombosis; Dabigatran; Apixaban; Rivaroxaban; Argatroban; Cancer;
CorrespondenceStability of direct oral anticoagulants in whole blood and plasma from patients in steady state treatment
Keywords: آپیکسابان; C; Celsius; DOAC; Direct oral anticoagulant; Anticoagulants; Apixaban; Dabigatran; Drug monitoring; DOAC; Rivaroxaban;
¿Son los nuevos anticoagulantes orales iguales a las antivitaminas K para la isquemia aguda de los miembros inferiores? Revisión sistemática de la evidencia
Keywords: آپیکسابان; Isquemia aguda de miembros inferiores; Fibrilación auricular; Antagonistas de la vitamina K; Apixaban; Dabigatran; Rivaroxaban; Acute limb ischaemia; Auricular fibrillation; Vitamin K antagonists; Apixaban, Dabigatran; Rivaroxaban;
Efficacy and safety of novel anticoagulants versus vitamin K antagonists in patients with mild and moderate to severe renal insufficiency: Focus on apixaban
Keywords: آپیکسابان; Anticoagulation; Apixaban; Atrial fibrillation; Novel anticoagulants; Warfarin;
Dosage plasmatique de quatre anticoagulants directs par UHPLC/DAD
Keywords: آپیکسابان; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Chromatographie liquide; Extraction en phase solide; Apixaban; Dabigatran; Edoxaban; Rivaroxaban; Liquid chromatography; Solid phase extraction;
Reversal Agents for the New Generation of Oral Anticoagulants: Implications for the Perioperative Physician
Keywords: آپیکسابان; novel oral anticoagulants; dabigatran; rivaroxaban; edoxaban; apixaban; direct thrombin inhibitor; factor Xa; atrial fibrillation; activated charcoal; prothrombin complex concentrates; vitamin K antagonists; warfarin; recombinant factor VIIa; idarucizumab
Nonvitamin K Anticoagulant Agents in Patients With Advanced Chronic Kidney Disease or on Dialysis With AF
Keywords: آپیکسابان; apixaban; dabigatran; edoxaban; renal dialysis; rivaroxaban; strokeACC, American College of Cardiology; AF, atrial fibrillation; AHA, American Heart Association; CI, confidence interval; CKD, chronic kidney disease; CrCl, creatinine clearance; ESRD, end-s
The effect of the direct factor Xa inhibitors apixaban and rivaroxaban on haemostasis tests: a comprehensive assessment using in vitro and ex vivo samples
Keywords: آپیکسابان; Haemostasis; coagulation; apixaban; rivaroxaban; anticoagulants; laboratory testing
An evidence summary of the management of patients taking direct oral anticoagulants (DOACs) undergoing dental surgery
Keywords: آپیکسابان; direct or novel or target-specific oral anticoagulant; DOAC; NOAC; TSOAC; dabigatran; rivaroxaban; apixaban; edoxaban; betrixaban; oral surgery
Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Keywords: آپیکسابان; Atrial fibrillation; NOAC; Dabigatran; Rivaroxaban; Apixaban; Edoxaban;
Cost-effectiveness of Apixaban Versus Other Oral Anticoagulants for the Initial Treatment of Venous Thromboembolism and Prevention of Recurrence
Keywords: آپیکسابان; apixaban; anticoagulants; cost-effectiveness; venous thromboembolism; vitamin;